Welcome to PsychU!

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

Loading Events

Virtual Event – Psychedelics For The Treatment Of Depression: Focus On 5HT-2A

The presenters will discuss the history of psychedelics in therapeutic approaches with a primary focus on psilocybin. They will also review the neurobiology of psychedelics and the role of 5-HT2A receptors, review the results of recently published findings, and discuss the challenges associated with psychedelic-assisted therapies.

Featuring

  • Philip G. Janicak, MD

    Adjunct Professor, Department of Psychiatry & Behavioral Sciences, Northwestern University Feinberg School of Medicine.

  • Rachel Self, PhD, MS (OPDC)

    Senior Medical Science Liaison

Philip G. Janicak, MD is a consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. Rachel Self, PhD, MS is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.